Download PDF
Thromb Haemost 1998; 79(04): 853-858
DOI: 10.1055/s-0037-1615077
Rapid Communication
Schattauer GmbH

Adenosine 3’:5’-Cyclic Monophosphate Induces Regulated Secretion of Tissue-Type Plasminogen Activator and von Willebrand Factor from Cultured Human Endothelial Cells

R. J. Hegeman
1   From the Gaubius Laboratory TNO-PG, Leiden, The Netherlands
,
van den Y. Eijnden-Schrauwen
1   From the Gaubius Laboratory TNO-PG, Leiden, The Netherlands
,
J. J. Emeis
1   From the Gaubius Laboratory TNO-PG, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 10 October 1997

Accepted after resubmission 12 December 1997

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

The effect of compounds increasing intracellular adenosine 3’:5’-cyclic monophosphate [cAMP]i levels (prostacyclin, isoproterenol, forskolin, cholera toxin), and of the cAMP analogs 8-bromo-cAMP and dibutyryl-cAMP, on the regulated secretion (acute release) of tissue-type plasminogen activator (tPA) and von Willebrand factor (vWF) was studied in cultured human umbilical vein endothelial cells (HUVEC).

Prostacyclin, isoproterenol and forskolin, which increased [cAMP]i in HUVEC, and the cell-permeant cAMP analog 8-bromo-cAMP induced dose- and time-dependent secretion of tPA and vWF. The extent of vWF and tPA release correlated with [cAMP]i, and was increased by the phosphodiesterase inhibitor isobutylmethylxanthine.

In contrast to thrombin, the cAMP-elevating agents did not increase the intracellular calcium concentration [Ca2+]i in HUVEC. At sub-maximal concentrations, the effects of thrombin and prostacyclin were additive.

Our results show that an increase in [cAMP]i resulted in regulated secretion (acute release) of tPA and vWF from HUVEC, without the concomitant increase in [Ca2+]i which is, in HUVEC, essential for thrombin-induced regulated secretion to occur. cAMP-induced secretion represents a novel mechanism for causing regulated secretion of tPA and vWF from endothelial cells.

 

  • References

  • 1 van Hinsbergh VWM. ed. Vascular control of haemostasis. Gordon and Breach Science Publishers; Victoria, Australia: 1996
    Google Scholar
  • 2 Ewenstein BM. Vascular biology of von Willebrand factor. In: Vascular endothelium. Physiology, pathology and therapeutic opportunities. Born GVA, Schwartz CJ, eds. Stuttgart: Schattauer Verlag; 1997: 107-22.
    Google Scholar
  • 3 Emeis JJ, van den Eijnden-Schrauwen Y, Kooistra T. Tissue-type plasminogen activator and the vessel wall: synthesis, storage and secretion. In: Vascular control of haemostasis. Van Hinsbergh VWM. ed. Victoria: Gordon and Breach Science Publishers; 1996: 187-206.
    Google Scholar
  • 4 Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990; 63: 454-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Birch KA, Pober JS, Zavoico GB, Means AR, Ewenstein BM. Calcium/ calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells. J Cell Biol 1992; 118: 1501-10.
    CrossrefPubMedGoogle Scholar
  • 6 van den Eijnden-Schrauwen Y, Atsma DE, de Vries REM, Lupu F, Kooistra T, Emeis JJ. On the involvement of calcium and G-proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 2177-87.
    CrossrefPubMedGoogle Scholar
  • 7 Vischer UM, Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis. Thromb Haemost 1997; 77: 1182-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 van den Eijnden-Schrauwen Y, Kooistra T, de Vries REM, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85: 3510-7.
    PubMedGoogle Scholar
  • 9 Schrauwen Y, Emeis JJ, Kooistra T. A sensitive ELISA for human tissue-type plasminogen activator applicable to the study of acute release from cultured human endothelial cells. Thromb Haemost 1994; 71: 225-9.
    PubMedGoogle Scholar
  • 10 Kooistra T, Berg J van den, Töns A, Platenburg G, Rijken DC, Berg E van den. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J 1987; 247: 605-12.
    CrossrefPubMedGoogle Scholar
  • 11 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
    PubMedGoogle Scholar
  • 12 Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann New York Acad Sci 1992; 667: 249-58.
    CrossrefPubMedGoogle Scholar
  • 13 Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Westmuckett A, Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol 1997; 139: 245-56.
    CrossrefPubMedGoogle Scholar
  • 14 Putney JW. Identification of cellular activation mechanisms associated with salivary secretion. Ann Rev Physiol 1986; 48: 76-88.
    PubMedGoogle Scholar
  • 15 Vajanaphanich M, Schultz C, Tsien RY, Traynor-Kaplan AE, Pandol SJ, Barrett KE. Cross-talk between calcium and cAMP-dependent intracellular signaling pathways. J Clin Invest 1995; 96: 386-93.
    CrossrefPubMedGoogle Scholar
  • 16 Mannucci PM. Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cAMP?. Thromb Res 1974; 4: 539-49.
    CrossrefPubMedGoogle Scholar
  • 17 Carson M, Shasby SS, Shasby DM. Histamine and inositol phosphate accumulation in endothelium: cAMP and G-protein. Am J Physiol 1989; 257: L259-64.
    PubMedGoogle Scholar
  • 18 Griesmacher A, Weigel G, David M, Horvath G, Mueller MM. Functional implications of cAMP and Ca2+ on prostaglandin I2 and thromboxane A2 synthesis by human endothelial cells. Arterioscler Thromb 1992; 12: 512-8.
    CrossrefPubMedGoogle Scholar
  • 19 Garcia JGN, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coag Fibrinol 1995; 6: 609-26.
    CrossrefPubMedGoogle Scholar
  • 20 Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VWM. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res 1995; 76: 199-208.
    CrossrefPubMedGoogle Scholar
  • 21 Prowse CV, MacGregor IR. Regulation of the plasminogen activator level in blood. In: Tissue-type plasminogen activator (t-PA): physiological and clinical aspects. Kluft C. ed. Boca Raton, FL: CRC Press; 1988. 2 49-66.
    Google Scholar
  • 22 Chandler WL, Levy WC, Stratton JR. The circulatory regulation of tPA and uPA secretion, clearance and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation 1995; 92: 2984-94.
    CrossrefPubMedGoogle Scholar
  • 23 Mariani G, Mannucci PM, Cattaneo M. eds. Desmopressin in bleeding disorders. New York: Plenum Press; 1993
    Google Scholar
  • 24 Wall U, Jern S, Tengborn L, Jern C. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood. 1998 in press.
    PubMedGoogle Scholar